Lantern Pharma

The first-ever AI 75 — the most innovative people in artificial intelligence in Dallas-Fort Worth — is revealed on May 2 at Convergence AI.

Presenting the First-Ever AI 75: Meet the Most Innovative Leaders in Artificial Intelligence in Dallas-Fort Worth

by | May 2, 2024
Dallas Innovates, the Dallas Regional Chamber, and Dallas AI have teamed up to launch the inaugural AI 75 list. The 2024 program honors the most significant people in AI in DFW in seven categories—the visionaries, creators, and influencers you need to know.
Lantern Pharma Subsidiary Starlight Therapeutics Names New Chief Medical Officer to Oversee Clinical Trials
by | Jan 19, 2024

Marc Chamberlain, M.D., has been appointed as the Chief Medical Officer at Starlight Therapeutics.

Starlight Therapeutics is a Dallas-based Lantern Pharma subsidiary focused exclusively on the clinical development of therapies for central nervous system and brain cancers with limited or no effective therapeutic options.

In his role as CMO, Chamberlain will oversee the company’s upcoming clinical trials focused on several serious and complex brain-related conditions: glioblastoma and other high-grade gliomas (aggressive types of brain tumor), brain metastases in adults (secondary brain tumors originating from cancer elsewhere in the body), and two types of pediatric brain tumors — atypical teratoid rhabdoid tumors (ATRT) and diffuse intrinsic pontine glioma (DIPG)....

Busting the Brain’s Firewall: How Lantern Pharma’s Algorithms Can Predict a Drug’s Ability to Reach the Brain
by | May 2, 2023
The "blood-brain barrier" acts like a highly selective firewall, preventing an estimated 98% of drugs from entering the brain—making it a major hurdle in the development of brain and central nervous system drugs. Lantern Pharma has recently developed what it calls "highly accurate AI algorithms" to predict the ability of a drug or compound to pass through the barrier.
Lantern Pharma Adds VP of Clinical Development, Additional Team Members
by | Mar 2, 2023

Dallas-based Lantern Pharma Inc. has expanded its clinical development team with the addition of Dr. Reggie Ewesuedo as vice president of clinical development, and several additional team members....


Here Are the Winners of The Innovation Awards 2023

by | Jan 17, 2023
Dallas Innovates and D CEO celebrated 68 honorees and revealed the winners of our fourth-annual Innovation Awards at an event held at On the Levee in the Dallas Design District. Here's a full list of winners and finalists.
Meet the Finalists: The Innovation Awards 2023, Presented by Dallas Innovates and D CEO
by | Nov 3, 2022
Now in its fourth year, the program from Dallas Innovates and D CEO honors 68 disruptors and trailblazers driving a new vision for innovation in North Texas. Finalists will be recognized in the January/February issue of D CEO magazine and online at Winners will be revealed at an exclusive awards event in January.
Meet the Finalists: The Innovation Awards 2022, Presented by Dallas Innovates and D CEO
Now in its third year, the program from Dallas Innovates and D CEO honors 78 disruptors and trailblazers driving a new vision for innovation in North Texas.
6 Dallas Innovators You Need to Know Today—and Why
by | Sep 2, 2021
Sally Beauty tapped its first-ever female CEO, NTT DATA gets a digital transformation leader, and more senior leadership moves this week.

Dallas’ Lantern Pharma Hits Major Milestone on its AI Platform to Advance its Oncology Drug Research and Development

by | Nov 18, 2020
Lantern Pharma amassed 1 billion data points on its proprietary artificial intelligence platform, which it believes is the most of any company in biotech. Now, the company is able to reduce cost, time, and risk to establish a more sustainable route in oncology drug development.
urban air
DI People: Lantern Pharma, The Richards Group, and RKD Announce Leadership Moves
by | Dec 17, 2019
In this weekly roundup of executive and leadership moves by companies and organizations in North Texas, you'll also find news from Colonial Savings, Crawford & Co., Kubota, North Dallas Bank & Trust Co., Amy Stewart Law, and Communities Foundation of Texas.
Lantern Pharma cancer
Lantern Pharma Teams Up with National Cancer Institute to Predict Drug Effectiveness on Tumors
by | Oct 7, 2019
This alum of Dallas startup accelerator Health Wildcatters is working with the National Cancer Institute's Developmental Therapeutics Branch on precision research and treatments.
artificial intelligence
Digital Assist: 5 North Texas Startups Making Their Mark With Artificial Intelligence
by | Apr 25, 2018
AI startups across the U.S. raised a record $1.9 billion in VC funding during the first quarter of 2018. From marketing to health care, here's a look at North Texas companies disrupting industries with AI tech.